drugset / Trial / NCT00288652

[S,S]-Reboxetine Dose-Range Finding Trial

NCT00288652

Phase 2 Completed 280 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of different doses of \[S,S\]-Reboxetine in the treatment of chronic pain following a shingles infection

Timeline

Start
2006-03
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject [S,S]-Reboxetine Unknown

Indications

No indication recorded.